Teva Pharmaceutical Industries Ltd (TEVA)
10.18
+1.26 +14.13%
NYSE
Jul 28, 13:22
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 16.28B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.63 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -3.982B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 47.16% |
| Profit Margin (Quarterly) | 1.93% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 11.17B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 0.6875 |
| PE Ratio | -- |
| Price to Book Value | 1.116 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 2.498 |
| Free Cash Flow (Quarterly) | -555.00M |
| Return on Equity | Upgrade |
View All TEVA News
News
-
WireHeadlineTime (ET)
-
Yahoo07/28 12:03
-
PR Newswire07/28 10:45
-
MT Newswires07/28 08:23
-
Yahoo07/28 08:07
-
Yahoo07/28 07:44
-
Yahoo07/28 07:34
-
Yahoo07/28 07:30
-
MT Newswires07/28 07:06
-
MT Newswires07/28 07:06
-
Yahoo07/28 07:02
-
Yahoo07/28 07:00
-
Yahoo07/23 05:51
-
SA Breaking News07/21 15:05
-
Yahoo07/21 08:00
-
PR Newswire07/20 10:50
-
Yahoo07/20 10:49
-
SA Breaking News07/08 10:42
-
SA Breaking News07/07 06:49
-
Yahoo07/02 11:46
-
Yahoo07/01 12:14
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 07/28/2021 | Earnings Results | Q2 2021 Earnings Results |
| 07/28/2021 08:00 EST | Earnings Calls | Q2 2021 Earnings Call |
| 06/14/2021 09:30 EST | AGM | 2021 Annual General Meeting |
| 04/28/2021 | Earnings Results | Q1 2021 Earnings Results |
| 04/28/2021 08:00 EST | Earnings Calls | Q1 2021 Earnings Call |
| 02/10/2021 | Earnings Results | Q4 2020 Earnings Results |
| 02/10/2021 08:00 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/05/2020 | Earnings Results | Q3 2020 Earnings Results |
| 11/05/2020 08:00 EST | Earnings Calls | Q3 2020 Earnings Call |
| 08/05/2020 08:00 EST | Earnings Calls | Q2 2020 Earnings Call |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.
- URL: https://www.tevapharm.com
- Investor Relations URL: https://ir.tevapharm.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Mid Cap/Value
- Next Earnings Release: Jul. 28, 2021
- Last Earnings Release: Jul. 28, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 27, 2017
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 10.18 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| EIS | iShares MSCI Israel ETF | 5.10% |
| ISRA | VanEck Vectors Israel ETF | 3.92% |
| BMPEX | Beck, Mack & Oliver Partners | 3.88% |
| PPH | VanEck Vectors Pharmaceutical ETF | 3.14% |
| MVISX | Miller Opportunity IS | 2.68% |
| CCM8341 | IA Clarington Global Opportunities FX (USD) | 2.52% |
| MKIEX | McKee International Equity Instl | 2.14% |
| MFCCX | Meridian Contrarian C | 1.73% |
| PPYPX | PIMCO RAE International I-2 | 0.94% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- TEVA Tweets Stocktwits
Advertisement
